Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely created TPD procedures. In this evaluate, we give attention to both preclinical experiments and clinical trials to offer a comprehensive summary of the security and clinical performance of PROTACs and MGDs in hematologic malignancies over the https://edmundg196vae9.yourkwikimage.com/user